Reproductive HealthFDA Approved
PT-141
Bremelanotide
Melanocortin agonist for sexual function.
❤️ Libido
Mechanism of Action
Activates MC4R in brain.
Key Benefits
- Increased desire
- Erectile function
Common Uses
Low libido
What to Expect
Onset
1–4 hours after injection; effects build gradually then peak
Duration
Primary effects last 6–12 hours; some residual arousal and warmth can persist up to 72 hours
What Users Report
- A genuine, spontaneous increase in sexual desire — not forced or mechanical, but a natural-feeling 'wanting'
- Works fundamentally differently from PDE5 inhibitors (Viagra/Cialis) — it creates desire at the brain level, not just blood flow
- Flushing and warmth in the face and body within 30–60 minutes, which is a sign the peptide is active
- Nausea in the first 30–60 minutes is common, especially at higher doses — most users find this manageable and temporary
- Both men and women report heightened sensitivity to touch and more intense physical sensations
- Effects can carry over into the next day — many report continued elevated libido for 24–48 hours
- Some users experience darkening of moles or a subtle tan from the melanocortin activity
Typical Timeline
Minutes 30–60: Flushing, warmth, possible nausea. Hours 1–2: Desire begins building. Hours 2–4: Peak arousal and heightened sensitivity. Hours 4–12: Sustained elevated libido. Hours 12–72: Residual effects gradually fade.
Side Effects
- Nausea, flushing
Dosage Protocol
1–2 mg subcutaneously or nasal as needed (2–4 hours before activity). Cycles: On-demand; limit 2–3x/week.
Always consult a physician before starting any peptide protocol.
Administration
Injection or nasal
FDA Status
FDA-approved (Vyleesi) for women
Stacks Well With
- Kisspeptin-10
Tags
#libido#sexual-health